Gomez Dennis, Aouali Nassera, Renaud Alexandra, Douarre Céline, Shin-Ya Kazuo, Tazi Jamal, Martinez Sophie, Trentesaux Chantal, Morjani Hamid, Riou Jean-François
Onco-Pharmacologie, Unité Mixte de Recherche (UMR), 6142 Centre National de la Recherche Scientifique (CNRS), Unité de Formation et de Recherche de Pharmacie, Université de Reims Champagne-Ardenne, 51096 Reims Cedex, France.
Cancer Res. 2003 Oct 1;63(19):6149-53.
The molecular mechanisms induced by G-quadruplex ligands to trigger senescence in mammalian cells are still unknown, although the critical role of telomerase is highly suspected. JFA2 cells selected for resistance to senescence induced by the G-quadruplex ligand 12459 presented an overexpression of hTERT transcript that correlated to a functional increase in telomerase activity and telomere length. Consistently, treatment with 12459 failed to trigger senescence and telomere shortening in JFA2 cells. Resistant cells also presented cross-resistance for senescence induction to telomestatin, another G-quadruplex ligand from a different series, but not to other anticancer agents, indicating the selectivity of the resistance mechanism. We, thus, provide evidence that telomerase activity and telomere length are key cellular determinants of the resistance to G-quadruplex ligands.
尽管高度怀疑端粒酶起关键作用,但G-四链体配体诱导哺乳动物细胞衰老的分子机制仍然未知。对G-四链体配体12459诱导的衰老具有抗性的JFA2细胞呈现hTERT转录本的过表达,这与端粒酶活性和端粒长度的功能性增加相关。一致地,用12459处理未能在JFA2细胞中触发衰老和端粒缩短。抗性细胞对另一种来自不同系列的G-四链体配体端粒抑素的衰老诱导也呈现交叉抗性,但对其他抗癌剂没有交叉抗性,表明抗性机制的选择性。因此,我们提供证据表明端粒酶活性和端粒长度是对G-四链体配体抗性的关键细胞决定因素。